ARGX:NASDAQ
argenx SE - ADR
$846.81
arrow_upward
+4.14%(+33.67) 1D
Jun 4, 3:21:02 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$826.72
High
$850.25
Low
$822.00
Mkt. cap
52.41B
Avg. vol.
315.26K
Volume
168.20K
P/E ratio
37.64
52-wk high
$934.62
52-wk low
$510.06
EPS
$22.51
Beta
0.47
Shares outstanding
61.88M
No. of employees
2K
Open
$826.72
High
$850.25
Low
$822.00
Mkt. cap
52.41B
Avg. vol.
315.26K
Volume
168.20K
P/E ratio
37.64
52-wk high
$934.62
52-wk low
$510.06
EPS
$22.51
Beta
0.47
Shares outstanding
61.88M
No. of employees
2K
Analyst outlook
Analyst Ratings
Based on 17 analysts giving stock ratings to ARGX in the past 3 months
Strong Buy
Buy
16
Hold
1
Sell
0
12 month forecast
Based on 17 Wall Street analysts offering 12 month price targets for ARGX in the last 3 months.
Highest
Current $846.81
$1,291.00 (+52.45%)
Average
$1,064.75 (+25.74%)
Lowest
$850.00 (+0.38%)
News stories
From sources across the web
GuruFocus
·
5 hours ago
ARGX Reiterated by Wedbush -- Maintains Price Target at $1000
Investing.com
·
7 hours ago
H.C. Wainwright reiterates Buy on argenx stock, $940 target
TradingView
·
23 hours ago
ARGX: Sustained growth, pipeline expansion, and disciplined pricing drive long-term value
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR
AI content may include mistakes. Learn more